Product Name: Daclatasvir Dihydrochloride
Formulae hypotheticae: C40H51ClN8O6
M. Pondus; 775.35
CAS Subcriptio Number; 1009119-65-6
Daclatasvir Dihydrochloride
Product nomen:Daclatasvir Dihydrochloride 1009119-65-6
Nomen
Daclatasvir Dihydrochloride
Synonyma
BMS790052;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1- (1-methylethyl)-2-oxo-2,1-ethanediyl]]] bisca rbamicaciddimethylesterhydrochloride;BMS 790052; BMS790052; BMS790052; DACLATASVIR; BMS 790052DIHYDROCHLORIDE; BMS790052DIHYDROCHLORIDE; BMS790Chemic albook052DIHYDROCHLORIDE; BMS 790052; BMS790052; BMS790052; henyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-;
M
Formulae hypotheticae
C40H51ClN8O6
M. Pondus
775.35
CAS Subcriptio Number
1009119-65-6
Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.
Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum